Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (chenopodium album pollen extract); allergen extracts 1 ic/ml (chenopodium album pollen extract); allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (equine epithelium extract); allergen extracts 1 ic/ml (equine epithelium extract); allergen extracts 10 ic/ml (equine epithelium extract) - solution for injection - active: allergen extracts 0.1 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (equine epithelium extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (rumex acetosa pollen extract); allergen extracts 1 ic/ml (rumex acetosa pollen extract); allergen extracts 10 ic/ml (rumex acetosa pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - dust allergens, quantity: 0.97 ml/ml (equivalent: dust allergens, qty 97 mg/ml); dust allergens, quantity: 0.01 ml/ml (equivalent: dust allergens, qty 1 mg/ml); feathers, quantity: 0.003 ml/ml (equivalent: feathers, qty 0.3 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata -

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - grass pollen extract 100 ir; allergen extracts 300 ir (grass pollen) - sublingual tablet - active: grass pollen extract 100 ir excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose active: allergen extracts 300 ir (grass pollen) excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.

Marekani - Kiingereza - NLM (National Library of Medicine)

alk-abello, inc. - carrot (unii: l56z1jk48b) (carrot - unii:l56z1jk48b) - carrot 0.1 mg in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater r

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - olea europaea, quantity: 10 ir/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; mannitol; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.